We did not find differences in immune pathways between COVID-19 and non-COVID-19 patients that are expected to be active in COVID-19 such as type 1 interferon signalling pathway (WP4868), TGF-beta signalling pathway (WP366), IL-1 or IL-6 signalling pathway (WP2332, WP364). Here, IL6 is linked to COVID-19.